CRTHF (CARsgen Therapeutics Holdings) Total Assets: $183.46 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CRTHF CARsgen Therapeutics Holdings Ltd CRTHF
21 GF Score
Price $1.91
! 3 Warning Signs
View Full Analysis

What is CARsgen Therapeutics Holdings Total Assets?

CARsgen Therapeutics Holdings CRTHF 21 Total Assets is $183.46 Mil as of Dec. 2025. GuruFocus rates CRTHF with a GF Score™ of 21/100. The stock has 3 warning signs investors should review.

CARsgen Therapeutics Holdings's Total Assets for the quarter that ended in Dec. 2025 was $183.46 Mil.

During the past 12 months, CARsgen Therapeutics Holdings's average Total Assets Growth Rate was -3.40% per year. During the past 3 years, the average Total Assets Growth Rate was -28.70% per year. During the past 5 years, the average Total Assets Growth Rate was -12.30% per year.

During the past 7 years, CARsgen Therapeutics Holdings's highest 3-Year average Total Assets Growth Rate was 29.40%. The lowest was -30.30%. And the median was -3.70%.

Total Assets is connected with ROA %. CARsgen Therapeutics Holdings's annualized ROA % for the quarter that ended in Dec. 2025 was -3.24%. Total Assets is also linked to Revenue through Asset Turnover. CARsgen Therapeutics Holdings's Asset Turnover for the quarter that ended in Dec. 2025 was 0.05.

CARsgen Therapeutics Holdings  (OTCPK:CRTHF) Total Assets Explanation

Total Assets is connected with ROA %.

CARsgen Therapeutics Holdings's annualized ROA % for the quarter that ended in Dec. 2025 is

ROA %=Net Income (Q: Dec. 2025 )/( (Total Assets (Q: Jun. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=-6.396/( (210.767+183.459)/ 2 )
=-6.396/197.113
=-3.24 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

CARsgen Therapeutics Holdings's Asset Turnover for the quarter that ended in Dec. 2025 is

Asset Turnover
=Revenue (Q: Dec. 2025 )/( (Total Assets (Q: Jun. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=10.606/( (210.767+183.459)/ 2 )
=10.606/197.113
=0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

CARsgen Therapeutics Holdings Total Assets Related Terms

CARsgen Therapeutics Holdings Total Assets Historical Data

* Premium members only.

The historical data trend for CARsgen Therapeutics Holdings's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CARsgen Therapeutics Holdings Total Assets Chart

CARsgen Therapeutics Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Assets
Get a 7-Day Free Trial 550.40 396.29 316.13 229.79 183.46

CARsgen Therapeutics Holdings Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 316.13 289.81 229.79 210.77 183.46
CRTHF
21GF Score
CARsgen Therapeutics Holdings Ltd CRTHF
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CARsgen Therapeutics Holdings Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

CARsgen Therapeutics Holdings's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (A: Dec. 2025 )+Total Liabilities (A: Dec. 2025 )
=110.651+72.808
=183.46

CARsgen Therapeutics Holdings's Total Assets for the quarter that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (Q: Dec. 2025 )+Total Liabilities (Q: Dec. 2025 )
=110.651+72.808
=183.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of $183.46 Mil mean?
CARsgen Therapeutics Holdings (CRTHF) has a Total Assets of $183.46 Mil as of Dec. 2025. The total amount of assets as recorded on a company's balance sheet. View historical data on CARsgen Therapeutics Holdings and its competitors.
Is CARsgen Therapeutics Holdings' Total Assets too high?
CARsgen Therapeutics Holdings' current Total Assets is $183.46 Mil. Overall, CARsgen Therapeutics Holdings has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does CARsgen Therapeutics Holdings' Total Assets compare to VRTX and REGN?
CARsgen Therapeutics Holdings' Total Assets of $183.46 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on CARsgen Therapeutics Holdings and its competitors. CARsgen Therapeutics Holdings's current Total Assets is $183.46 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CARsgen Therapeutics Holdings stock overvalued right now?
CARsgen Therapeutics Holdings (CRTHF) has a current Total Assets of $183.46 Mil. The current Total Assets is $183.46 Mil. CARsgen Therapeutics Holdings' overall GF Score™ is 21/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For CARsgen Therapeutics Holdings (CRTHF), the current Total Assets is $183.46 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CARsgen Therapeutics Holdings Business Description

Other Exchanges 02171:Hong Kong
Address No. 466 Yindu Road, Building 2, 1st Floor, Xuhui District, Shanghai, CHN
CARsgen Therapeutics Holdings Ltd is a clinical-stage biopharmaceutical company discovering, researching, and developing cell therapies in the People's Republic of China and the United States of America. During the year, a majority of the Group's revenue was derived from one customer located in the Chinese mainland.
21GF Score

Get the complete analysis for CRTHF

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.91
Price